Retour
Fourchette du Jour
11,52 €
11,52 €
Fourchette 52 Semaines
11,52 €
13,40 €
Volume
120
Moyenne 50J / 200J
11,52 €
/
11,52 €
Clôture Précédente
11,52 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 11,9 | 3,7 |
| Net Margin % | 12,1 | 3,8 |
| Rev Growth 5Y % | 0,2 | 10,0 |
| D/E | 0,5 | 0,2 |
Points Clés
Revenue grew 0,24% annually over 5 years — modest growth
Earnings grew 67,49% over the past year
ROE of 11,87% — decent returns on equity
Generating 337,00M in free cash flow
P/E of 0,06 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,64%
Croissance
Revenue Growth (5Y)
0,24%
Revenue (1Y)6,88%
Earnings (1Y)67,49%
FCF Growth (3Y)N/A
Qualité
Return on Equity
11,87%
ROIC5,88%
Net Margin12,13%
Op. Margin11,01%
Sécurité
Debt / Equity
0,53
Current Ratio1,95
Interest Coverage20,03
Valorisation
P/E Ratio
0,06
P/B Ratio0,01
EV/EBITDA2,59
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,88% | Revenue Growth (3Y) | -2,87% |
| Earnings Growth (1Y) | 67,49% | Earnings Growth (3Y) | 34,57% |
| Revenue Growth (5Y) | 0,24% | Earnings Growth (5Y) | 16,76% |
| Profitability | |||
| Revenue (TTM) | 189,02B | Net Income (TTM) | 22,94B |
| ROE | 11,87% | ROA | 6,47% |
| Gross Margin | 29,81% | Operating Margin | 11,01% |
| Net Margin | 12,13% | Free Cash Flow (TTM) | 337,00M |
| ROIC | 5,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,53 | Current Ratio | 1,95 |
| Interest Coverage | 20,03 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,06 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | -0,27 |
| EV/EBITDA | 2,59 | Dividend Yield | 0,02% |
| Market Cap | 1,33B | Enterprise Value | 53,88B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 189,02B | 176,86B | 200,34B | 193,82B | 187,22B |
| Net Income | 22,94B | 13,70B | 12,67B | -28,27B | 12,34B |
| EPS (Diluted) | 184,45 | 311,80 | 96,20 | -645,54 | 281,52 |
| Gross Profit | 56,35B | 54,32B | 62,63B | 66,65B | 72,43B |
| Operating Income | 20,81B | 18,62B | 16,39B | -4,45B | 18,89B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 354,62B | 382,02B | 364,17B | 349,50B | 393,34B |
| Total Liabilities | 180,77B | 163,99B | 151,43B | 149,42B | 152,59B |
| Shareholders' Equity | 173,85B | 212,66B | 201,64B | 190,07B | 218,28B |
| Total Debt | 91,34B | 82,89B | 77,07B | 71,23B | 71,85B |
| Cash & Equivalents | 38,79B | 26,37B | 33,08B | 47,72B | 54,27B |
| Current Assets | 200,82B | 239,99B | 205,35B | 202,12B | 205,67B |
| Current Liabilities | 102,82B | 77,35B | 85,15B | 88,84B | 80,45B |